Mga Batayang Estadistika
| CIK | 1107332 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| June 10, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 10, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| June 3, 2015 |
EX-99.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE x : In re: : Chapter 11 : DENDREON CORPORATION, et al., : Case No. 14-12515 (LSS) : Debtors.1 : Jointly Administered : : x SECOND AMENDED PLAN OF LIQUIDATION PURSUANT TO CHAPTER 11 OF THE BANKRUPTCY CODE PROPOSED BY THE DEBTORS Nothing contained herein shall constitute an offer, an acceptance or a legally binding obligation |
|
| June 3, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 2, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| June 2, 2015 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 2, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| May 21, 2015 |
Exhibit 99.2 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - In re: DENDREON CORPORATION, et al., Debtors.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x : : : : : : : : x Chapter 11 Case No. 14-12515 (LSS) Jointly Administered SECOND AMENDED PLAN OF LIQUIDATION PU |
|
| May 21, 2015 |
Exhibit 99.1 THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - In re: DENDREON CORPORATION, et al., Debtors.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x : : : : : : : : x Chapter 11 Case No. 14-12515 (LSS) Jointly Administered NOTICE OF FILING OF DEBTORS? MONTHLY OPERATING REPORT FOR THE PERIOD |
|
| May 21, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 20, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| April 21, 2015 |
Exhibit 99.1 THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x : In re: : Chapter 11 : DENDREON CORPORATION, et al., : Case No. 14-12515 (LSS) : Debtors.1 : Jointly Administered : : - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x NOTICE OF FILING OF DEBTORS? MONTHLY OPERATING REPORT FOR THE PERIOD |
|
| April 21, 2015 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 20, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| April 17, 2015 |
Exhibit 99.3 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x In re: DENDREON CORPORATION, et al., Debtors.1 : : : : : : : : : : Chapter 11 Case No. 14-12515 (LSS) Jointly Administered - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x ORDER (A) APPROVING THE FORM AND MANNER OF NOTICE OF THE |
|
| April 17, 2015 |
Exhibit 99.2 Solicitation Version IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x In re: DENDREON CORPORATION, et al., Debtors.1 : : : : : : : : Chapter 11 Case No. 14-12515 (LSS) Jointly Administered - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x FIRST AMENDED PLAN OF LIQUIDATION PURSUA |
|
| April 17, 2015 |
EX-99.1 2 d909903dex991.htm EX-99.1 Exhibit 99.1 Solicitation Version IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x In re: DENDREON CORPORATION, et al., Debtors.1 : : : : : : : : Chapter 11 Case No. 14-12515 (LSS) Jointly Administered - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x DISC |
|
| April 17, 2015 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 14, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commission |
|
| April 8, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 23, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commi |
|
| March 25, 2015 |
Exhibit 99.1 THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x : In re: : Chapter 11 : DENDREON CORPORATION, et al., : Case No. 14-12515 (LSS) : Debtors.1 : Jointly Administered : : - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x NOTICE OF FILING OF DEBTORS? MONTHLY OPERATING REPORT FOR THE PERIOD OF |
|
| March 25, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 20, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commi |
|
| March 11, 2015 |
Exhibit 99.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x : In re: : Chapter 11 : DENDREON CORPORATION, et al., : Case No. 14-12515 (LSS) : Debtors.1 : Jointly Administered : : - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x PLAN OF LIQUIDATION PURSUANT TO CHAPTER 11 OF THE BANKRUPTCY CODE |
|
| March 11, 2015 |
THIS DISCLOSURE STATEMENT HAS NOT YET BEEN APPROVED BY THE COURT Exhibit 99.2 THIS DISCLOSURE STATEMENT HAS NOT YET BEEN APPROVED BY THE COURT This proposed Disclosure Statement is not a solicitation of acceptance or rejection of the Plan of Liquidation Pursuant to Chapter 11 of the Bankruptcy Code Proposed by the Debtors. Acceptances or rejections may not be solicited until the Bankruptcy Code has approved this Disclosure Statement under section 1125 of the Ba |
|
| March 11, 2015 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 10, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commission |
|
| March 6, 2015 | ||
| March 6, 2015 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 9, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| March 6, 2015 |
Exhibit 99.1 IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE HERBERT SILVERBERG, Derivatively ) on Behalf of DENDREON ) CORPORATION, ) ) Plaintiff, ) ) v. ) C.A. No. 7646-VCP ) MITCHELL H. GOLD, RICHARD F. ) HAMM, GREGORY T. SCHIFFMAN, ) MARK W. FROHLICH, SUSAN B. ) BAYH, RICHARD B. BREWER, ) GERARDO CANET, BOGDAN ) DZIURZYNSKI, DAVID L. URDAL, and ) DOUGLAS G. WATSON, ) ) Defendants, ) ) -and- |
|
| February 27, 2015 |
Exhibit 10.1 Dendreon Corporation 101-J Morris Commons Lane Suite 145 Morrisville, North Carolina 27560 February 26, 2015 [Name] [Address] [Address] Dear [ ]: We are very pleased to extend this offer to join Dendreon Corporation (?Dendreon?) as [title], reporting directly to the Board of Directors of Dendreon. Your start date will be [ ]. This is a full-time, exempt position anticipated to have a |
|
| February 27, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 23, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Co |
|
| February 23, 2015 |
Exhibit 99.1 Exhibit 99.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x : In re: : Chapter 11 : DENDREON CORPORATION, et al., : Case No. 14-14-12515 : Debtors.1 : Jointly Administered : : Related Docket Nos. 17, 62, 124, 188, 195, 230, 396 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x ORD |
|
| February 23, 2015 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 19, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| February 20, 2015 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 19, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Co |
|
| February 20, 2015 |
EX-2.1 Exhibit 2.1 EXECUTION VERSION SECOND AMENDED AND RESTATED ACQUISITION AGREEMENT among DENDREON CORPORATION, DENDREON HOLDINGS, LLC, DENDREON DISTRIBUTION, LLC and DENDREON MANUFACTURING, LLC, as Sellers, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., as Valeant, and DRONE ACQUISITION SUB INC., as Purchaser Dated as of February 19, 2015 TABLE OF CONTENTS ARTICLE I THE ACQUISITION 2 Section 1.1 |
|
| February 20, 2015 |
8-K 1 d877954d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 20, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction |
|
| February 19, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 19, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Co |
|
| February 17, 2015 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 13, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Co |
|
| February 17, 2015 |
EX-99.1 Exhibit 99.1 THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x : In re: : Chapter 11 : DENDREON CORPORATION, et al., : Case No. 14-12515 (LSS) : Debtors.1 : Jointly Administered : : - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x NOTICE OF FILING OF DEBTORS’ MONTHLY OPERATING REPORT FOR TH |
|
| February 17, 2015 |
EX-99.2 Exhibit 99.2 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – X : In re: : Chapter 11 : DENDREON CORPORATION, et al., : Case No. 14-12515 (LSS) : Debtors.1 : Jointly Administered : : Related Docket No. 17, 62, 124, 188, 195, 230, 314, 330, 332, 355 – – – – – – – – – – – – – – – – – – – – – – – – – – – – |
|
| February 10, 2015 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 10, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Co |
|
| February 10, 2015 |
DNDN / / VANGUARD GROUP INC Passive Investment dendreoncorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2 )* Name of issuer: Dendreon Corp Title of Class of Securities: Common Stock CUSIP Number: 24823Q107 Date of Event Which Requires Filing of this Statement: December 31, 2014 Check the appropriate box to design |
|
| February 10, 2015 |
EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE DENDREON ANNOUNCES EXPIRATION OF BID DEADLINE IN CONNECTION WITH AGREEMENT TO SELL SUBSTANTIALLY ALL ASSETS TO VALEANT PROVENGE® (sipuleucel-T), the First Personalized Immunotherapy for Advanced Prostate Cancer, Included in the Sale and Remains Commercially Available Dendreon and Valeant to Seek Court Approval of Sale on February 20, 2015 SEATTLE – Februa |
|
| February 6, 2015 |
EX-2.1 Exhibit 2.1 EXECUTION VERSION AMENDED AND RESTATED ACQUISITION AGREEMENT among DENDREON CORPORATION, DENDREON HOLDINGS, LLC, DENDREON DISTRIBUTION, LLC and DENDREON MANUFACTURING, LLC, as Sellers, and VALEANT PHARMACEUTICALS INTERNATIONAL, INC., as Purchaser Dated as of February 4, 2015 TABLE OF CONTENTS ARTICLE I THE ACQUISITION 1 Section 1.1 Acquired Assets 1 Section 1.2 Excluded Assets 4 |
|
| February 6, 2015 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 4, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| February 6, 2015 |
EX-99.2 Exhibit 99.2 FOR IMMEDIATE RELEASE DENDREON ENTERS INTO AMENDED AGREEMENT WITH VALEANT IN CONNECTION WITH COURT-SUPERVISED SALES PROCESS PROVENGE® (sipuleucel-T), the First Personalized Immunotherapy for Advanced Prostate Cancer, Remains Commercially Available SEATTLE – February 5, 2015 – Dendreon Corporation (“Dendreon” or the “Company”) announced today that it has entered into an amended |
|
| February 6, 2015 |
EX-99.1 Exhibit 99.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x : : : : : : : : x In re: DENDREON CORPORATION, et al., Debtors.1 Chapter 11 Case No. 14-12515 (LSS) Jointly Administered Related Docket Nos. 17, 62, 195 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |
|
| February 2, 2015 |
EX-99.2 Exhibit 99.2 FOR IMMEDIATE RELEASE DENDREON REACHES AGREEMENT FOR VALEANT TO SERVE AS “STALKING HORSE BIDDER” IN COURT-SUPERVISED SALES PROCESS PROVENGE® (sipuleucel-T), the First Personalized Immunotherapy for Advanced Prostate Cancer, Remains Commercially Available SEATTLE – January 29, 2015 – Dendreon Corporation (“Dendreon” or the “Company”) announced today that it has reached an agree |
|
| February 2, 2015 |
EX-99.1 Exhibit 99.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x In re: DENDREON CORPORATION, et al., Debtors.1 : : : : : : : : Chapter 11 Case No. 14-12515 (LSS) Jointly Administered - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x Related Docket Nos. 17, 62, 195 DEBTO |
|
| February 2, 2015 |
EX-2.1 Exhibit 2.1 EXECUTION VERSION ACQUISITION AGREEMENT among DENDREON CORPORATION, DENDREON HOLDINGS, LLC, DENDREON DISTRIBUTION, LLC and DENDREON MANUFACTURING, LLC, as Sellers, and VALEANT PHARMACEUTICALS INTERNATIONAL, INC., as Purchaser Dated as of January 29, 2015 TABLE OF CONTENTS ARTICLE I THE ACQUISITION 1 Section 1.1 Acquired Assets 1 Section 1.2 Excluded Assets 4 Section 1.3 Assumed |
|
| February 2, 2015 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 29, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Com |
|
| January 27, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 27, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Com |
|
| January 22, 2015 |
Exhibit 99.1 Exhibit 99.1 EFiled: Jan 16 2015 11:16AM EST Transaction ID 56616875 Case No. 7646-VCP IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE HERBERT SILVERBERG, Derivatively ) on Behalf of DENDREON ) CORPORATION, ) ) Plaintiff, ) ) v. ) C.A. No. 7646-VCP ) MITCHELL H. GOLD, RICHARD F. ) HAMM, GREGORY T. SCHIFFMAN, ) MARK W. FROHLICH, SUSAN B. ) BAYH, RICHARD B. BREWER, ) GERARDO CANET, BO |
|
| January 22, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 16, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Com |
|
| January 22, 2015 |
EX-99.1 Exhibit 99.1 Dendreon Announces Strong Commercial Start to 2015 • Company begins new year exceeding 2014 revenue target and announces first commercial PROVENGE® (sipuleucel-T) patient outside U.S. starts treatment SEATTLE – (Business Wire) – JANUARY 14, 2015 – Dendreon Corporation today announced that the company grew sales in four quarters successively, exceeded its revenue target for the |
|
| January 22, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 14, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Com |
|
| January 21, 2015 |
Exhibit 99.1 THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE x In re: DENDREON CORPORATION, et al., Debtors.1 : : : : : : : : Chapter 11 Case No. 14-12515 (PJW) Jointly Administered x NOTICE OF FILING OF DEBTORS’ MONTHLY OPERATING REPORT FOR THE PERIOD OF DECEMBER 2014 PLEASE TAKE NOTICE that the above-captioned debtors and debtors in possession (collectively, the “Debtors”) have f |
|
| January 21, 2015 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 20, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| January 12, 2015 |
EX-99.1 2 d850358dex991.htm EX-99.1 Exhibit 99.1 UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE : In re : Chapter 11 : DENDREON CORPORATION, et al., : Case No. 14-12515 (LSS) : Debtors.1 : : Jointly Administered : SCHEDULE OF ASSETS AND LIABILITIES FOR DENDREON CORPORATION (CASE NO. 14-12515 (LSS)) 1 The Debtors and the last four digits of their respective taxpayer identification numbers are |
|
| January 12, 2015 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 9, 2015 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| December 30, 2014 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 29, 2014 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Co |
|
| December 29, 2014 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 24, 2014 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Co |
|
| December 29, 2014 |
EX-99.3 Exhibit 99.3 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE x : In re: : Chapter 11 : DENDREON CORPORATION, et al., : Case No. 14-12515 (PJW) : Debtors.1 : Jointly Administered : : x Related Docket Nos. 13, 58, 70, 143 FINAL ORDER PURSUANT TO BANKRUPTCY CODE SECTIONS 105(a), 362(a)(3), AND 541 AND BANKRUPTCY RULE 3001 ESTABLISHING NOTICE AND HEARING PROCEDURES FOR TRADI |
|
| December 29, 2014 |
EX-99.1 Exhibit 99.1 THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x : In re: : Chapter 11 : DENDREON CORPORATION, et al., : Case No. 14-12515 (PJW) : Debtors.1 : Jointly Administered : : - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x NOTICE OF FILING OF DEBTORS’ MONTHLY OPERATING REPORT FOR TH |
|
| December 29, 2014 |
EX-99.2 Exhibit 99.2 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE x : In re: : Chapter 11 : DENDREON CORPORATION, et al., : Case No. 14-12515 (PJW) : Debtors.1 : Jointly Administered : : x Related Docket Nos. 20, 164, 167, 173, 174 ORDER (A) AUTHORIZING THE DEBTORS TO ASSUME PLAN SUPPORT AGREEMENTS AND (B) GRANTING RELATED RELIEF Upon the motion (the “Motion”)2 of the Debtors |
|
| December 19, 2014 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 15, 2014 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| December 19, 2014 |
EX-99.1 Exhibit 99.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE x : In re: : Chapter 11 : DENDREON CORPORATION, et al., : Case No. 14-12515 (PJW) : Debtors.1 : Jointly Administered : : Related Docket No. 17, 62, 124 x ORDER (I) ESTABLISHING BIDDING PROCEDURES RELATING TO THE SALE OF SUBSTANTIALLY ALL OF THE DEBTORS’ ASSETS; (II) ESTABLISHING PROCEDURES FOR THE DEBTORS TO EN |
|
| December 19, 2014 |
DENDREON CORPORATION KEY EMPLOYEE INCENTIVE PLAN SECTION 1. PURPOSE EX-10.3 Exhibit 10.3 DENDREON CORPORATION KEY EMPLOYEE INCENTIVE PLAN SECTION 1. PURPOSE The purpose of the Key Employee Incentive Plan (the “Plan”) of Dendreon Corporation (the “Company”) is to provide selected key employees of the Company with certain payments upon the achievement of specified goals in connection with certain restructuring events of the Company. The awards payable under the Plan |
|
| December 19, 2014 |
AMENDED AND RESTATED PLAN SUPPORT AGREEMENT EX-10.2 Exhibit 10.2 EXECUTION VERSION AMENDED AND RESTATED PLAN SUPPORT AGREEMENT This AMENDED AND RESTATED PLAN SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of December 17, 2014 by and among (i) Dendreon Corporation (the “Company”) and its subsidiaries signatory hereto (collectively, and together with the Company, the “Debtors”), and (ii) each of the undersigned holders (the |
|
| December 19, 2014 |
AMENDED AND RESTATED PLAN SUPPORT AGREEMENT EX-10.1 2 d839676dex101.htm EX-10.1 Exhibit 10.1 EXECUTION VERSION AMENDED AND RESTATED PLAN SUPPORT AGREEMENT This AMENDED AND RESTATED PLAN SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of December 17, 2014 by and among (i) Dendreon Corporation (the “Company”) and its subsidiaries signatory hereto (collectively, and together with the Company, the “Debtors”), and (ii) each of t |
|
| December 12, 2014 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 11, 2014 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Co |
|
| December 2, 2014 |
Exhibit 99.1 Exhibit 99.1 B26 (Official Form 26) (12/08) IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE X : Chapter 11 In re : Case No. 14-12515 (PJW) DENDREON CORPORATION, et al., : Jointly Administered : Debtors.1 : X PERIODIC REPORT REGARDING VALUE, OPERATIONS AND PROFITABILITY OF ENTITIES IN WHICH THE ESTATE OF DENDREON CORPORATION HOLDS A SUBSTANTIAL OR CONTROLLING INTERES |
|
| December 2, 2014 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 1, 2014 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| November 26, 2014 |
Regulation FD Disclosure, Financial Statements and Exhibits Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 25, 2014 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Co |
|
| November 26, 2014 |
EX-99.1 Exhibit 99.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - In re: DENDREON CORPORATION, et al., Debtors.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x:::::::: x Chapter 11 Case No. 14-12515 (PJW) Jointly Administered NOTICE OF FILING OF INITIAL MONTHLY OPERATING REPORT PLEASE TAKE |
|
| November 12, 2014 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 10, 2014 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Co |
|
| November 10, 2014 |
2014 ANNUAL BONUS PROGRAM AGREEMENT EX-10.4 Exhibit 10.4 2014 ANNUAL BONUS PROGRAM AGREEMENT This Annual Bonus Program Agreement (this “Agreement”) is made and entered into effective as of November 4, 2014 (the “Effective Date”), between Dendreon Corporation (the “Company”), and Greg Cox (“Employee”). RECITALS A. As a Vice President or Executive Vice President, employee occupies a key position with the Company. In order to ensure th |
|
| November 10, 2014 |
KEY EMPLOYEE RETENTION INCENTIVE AGREEMENT Exhibit 10.3 KEY EMPLOYEE RETENTION INCENTIVE AGREEMENT This Key Employee Retention Incentive Agreement (this “Agreement”) is made and entered into effective as of November 4, 2014, 2014 (the “Effective Date”), between Dendreon Corporation (the “Company”), and Greg Cox (“Employee”). RECITALS A. Employee occupies a key position with the Company. In order to ensure the continued effective conduct of |
|
| November 10, 2014 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 4, 2014 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| November 10, 2014 |
In October 2014, the Company completed a reforecasting of its internal financial projections EX-99.2 In October 2014, the Company completed a reforecasting of its internal financial projections The revised projections include a “Baseline” case with layers for the impact of E.U. and Automation Projections: Certain Key Assumptions ($ in millions) CERTAIN KEY ASSUMPTIONS AUTOMATION Automation plan (Phase I only) requires $7.4 mm investment Q4 2014 through Q4 2015 Phase II automation is defin |
|
| November 10, 2014 |
FOURTH AMENDMENT TO SUPPLY AGREEMENT EX-10.1 Exhibit 10.1 FOURTH AMENDMENT TO SUPPLY AGREEMENT This Fourth Amendment to Supply Agreement (the “Fourth Amendment”) is made and entered into as of the 6th day of October 2014 by and between FUJIFILM Diosynth Biotechnologies U.S.A., Inc. (“FDBU”), a Delaware corporation with offices at 101 J. Morris Commons Lane, Morrisville, NC 27560, and Dendreon Corporation (“Dendreon”), a Delaware corp |
|
| November 10, 2014 |
DNDNQ / 10-Q - Quarterly Report - FORM 10-Q Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2014 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-35546 DENDREON CORPORATION (Exact name of registrant as specified in its charter) DELAWARE 22-3203193 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No. |
|
| November 10, 2014 |
EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE DENDREON REACHES AGREEMENTS ON TERMS OF FINANCIAL RESTRUCTURING Operations to Continue Without Interruption; PROVENGE® Remains Commercially Available Commences Voluntary Chapter 11 Proceedings to Implement Restructuring Agreements SEATTLE – November 10, 2014 – Dendreon Corporation (NASDAQ: DNDN) (“Dendreon” or the “Company”) today announced that it has re |
|
| November 10, 2014 |
EX-10.2 Exhibit 10.2 EXECUTION VERSION PLAN SUPPORT AGREEMENT This PLAN SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of November 9, 2014 by and among (i) Dendreon Corporation (the “Company”) and its subsidiaries signatory hereto (collectively, and together with the Company, the “Debtors”), and (ii) each of the undersigned holders (the “Supporting Noteholders”) of the Company’s |
|
| November 10, 2014 |
EX-10.1 Exhibit 10.1 EXECUTION VERSION PLAN SUPPORT AGREEMENT This PLAN SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of November 9, 2014 by and among (i) Dendreon Corporation (the “Company”) and its subsidiaries signatory hereto (collectively, and together with the Company, the “Debtors”), and (ii) each of the undersigned holders (the “Supporting Noteholders”) of the Company’s |
|
| August 12, 2014 |
Form S-8 As filed with the Securities and Exchange Commission on August 12, 2014 Registration No. |
|
| August 11, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2014 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-35546 DENDREON CORPORATION (Exact name of registrant as specified in its charter) DELAWARE 22-3203193 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No. |
|
| July 30, 2014 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 28, 2014 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commis |
|
| July 30, 2014 |
Dendreon Names W. Thomas Amick President and Chief Executive Officer EX-99.1 Exhibit 99.1 Dendreon Names W. Thomas Amick President and Chief Executive Officer SEATTLE, JULY 30, 2014 – Dendreon Corporation (Nasdaq: DNDN) today announced that its board of directors has appointed W. Thomas Amick as president and chief executive officer, effective immediately. Mr. Amick has also been appointed to the Company’s board of directors. Mr. Amick succeeds John H. Johnson, who |
|
| July 30, 2014 |
DENDREON CORPORATION EXECUTIVE EMPLOYMENT AGREEMENT EX-10.1 Exhibit 10.1 DENDREON CORPORATION EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (this “Agreement”) is effective as of July 28, 2014 (“Effective Date”), by and between Dendreon Corporation, a Delaware corporation (the “Company”), and W. Thomas Amick (“Employee”). The parties agree as follows: 1. Employment. The Company hereby employs Employee as Chief Executive Officer, |
|
| June 18, 2014 |
Termination of a Material Definitive Agreement Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 17, 2014 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commis |
|
| June 9, 2014 |
EX-99.1 Exhibit 99.1 Dendreon Announces Leadership Transition John H. Johnson to Step Down as Chairman, President and CEO; Douglas G. Watson Elected Chairman SEATTLE, June 9, 2014 – Dendreon Corporation (Nasdaq: DNDN) today announced that John H. Johnson has informed the Board of Directors of his plans to step down as president and chief executive officer for personal reasons. Mr. Johnson has resi |
|
| June 9, 2014 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 3, 2014 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| June 9, 2014 |
TRANSITION AND SEPARATION AGREEMENT EX-10.1 Exhibit 10.1 EXECUTION COPY TRANSITION AND SEPARATION AGREEMENT This Transition and Separation Agreement (the “Agreement”) is made as of June 9, 2014 by and between Dendreon Corporation, a Delaware corporation (the “Company”), and John Johnson (“Executive”). The Company and Executive are collectively referred to herein as the “Parties”. Capitalized terms not defined herein will have the me |
|
| May 22, 2014 |
DNDN / / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. |
|
| May 21, 2014 |
Submission of Matters to a Vote of Security Holders Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 15, 2014 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| May 8, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2014 Dendreon Corporation (Exact Name of Registrant as Specified in Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| May 8, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2014 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-35546 DENDREON CORPORATION (Exact name of registrant as specified in its charter) DELAWARE 22-3203193 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No. |
|
| May 8, 2014 |
EX-99.1 Exhibit 99.1 Dendreon Announces First Quarter 2014 Results – Conference Call to be Hosted May 8, 2014 at 9:00 a.m. ET – SEATTLE, May 8, 2014 – Dendreon Corporation (Nasdaq: DNDN) today reported results for the first quarter ended March 31, 2014. Net product revenue for the quarter was $68.8 million compared to $67.6 million in the first quarter of 2013. Net loss in the first quarter of 201 |
|
| April 21, 2014 |
DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 7, 2014 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 4, 2014 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commission |
|
| March 3, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 Commission File Number: 001-35546 DENDREON CORPORATION (Exact name of registrant as specified in its charter) DELAWARE (State or other jurisdiction of incorporation or organization) 22-3203193 (IRS Employer Identification No. |
|
| March 3, 2014 |
EX-21.1 Exhibit 21.1 Dendreon Corporation List of Subsidiaries Legal Name Jurisdiction Percent Owned Dendreon Holdings, LLC Delaware 100%1 Dendreon Distribution, LLC Delaware 100%2 Dendreon Manufacturing, LLC Delaware 100%3 Dendreon UK Limited England and Wales 100%4 Dendreon Holdings (Netherlands) B.V. The Netherlands 100%5 Dendreon Germany GmbH Germany 100%6 Dendreon Operations B.V. The Netherla |
|
| March 3, 2014 |
EX-99.1 Exhibit 99.1 Dendreon Announces Fourth Quarter and 2013 Year End Results – Conference Call to be Hosted March 3, 2014 at 9:00 a.m. ET – SEATTLE, March 3, 2014 – Dendreon Corporation (NASDAQ: DNDN) today reported results for the fourth quarter and full year ended December 31, 2013. Net product revenue for the year ended December 31, 2013 was $283.7 million compared to $325.3 million for the |
|
| March 3, 2014 |
EX-12 Exhibit 12 Dendreon Corporation Ratios of Earnings to Fixed Charges Year Ended December 31, Ratio of Earnings to Fixed Charges (in thousands) 2013 2012 2011 2010 2009 Earnings Loss before taxes ($ 296,804 ) ($ 393,610 ) ($ 337,806 ) ($ 439,891 ) ($ 220,161 ) Add: Fixed charges 56,839 58,349 52,427 7,078 5,174 Less: Capitalized interest — 290 1,186 3,539 1,374 Total earnings (as defined) (239 |
|
| March 3, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2014 Dendreon Corporation (Exact Name of Registrant as Specified in Charter) Delaware 001-35546 22-3203193 (State or Other Juris- diction of Incorporation) (Commissi |
|
| February 12, 2014 |
DNDN / / VANGUARD GROUP INC Passive Investment dendreoncorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1 )* Name of issuer: Dendreon Corp Title of Class of Securities: Common Stock CUSIP Number: 24823Q107 Date of Event Which Requires Filing of this Statement: December 31, 2013 Check the appropriate box to design |
|
| February 6, 2014 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 3, 2014 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| January 21, 2014 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 20, 2014 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Com |
|
| January 13, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 13, 2014 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Com |
|
| January 13, 2014 |
Dendreon Announces Preliminary Fourth Quarter 2013 Revenues Exhibit 99.1 Dendreon Announces Preliminary Fourth Quarter 2013 Revenues SEATTLE, January 13, 2014 – Dendreon Corporation (NASDAQ: DNDN) today announced preliminary revenues for the fourth quarter ended December 31, 2013. Net product revenue for the quarter is expected to be approximately $74.8 million, up 10.1% on a sequential basis. Recent Highlights: • Business has continued to strengthen • Com |
|
| January 13, 2014 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 13, 2014 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Com |
|
| December 19, 2013 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 19, 2013 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Co |
|
| November 12, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2013 Dendreon Corporation (Exact Name of Registrant as Specified in Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commis |
|
| November 12, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2013 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-35546 DENDREON CORPORATION (Exact name of registrant as specified in its charter) DELAWARE 22-3203193 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No. |
|
| November 12, 2013 |
Costs Associated with Exit or Disposal Activities - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 12, 2013 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 000-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Co |
|
| November 12, 2013 |
EX-99.1 Exhibit 99.1 Dendreon Announces Third Quarter 2013 Results – Implements Restructuring and Cost Reduction Plan Projected to Generate More Than $125 Million in Annual Savings – – Conference Call to be Hosted November 12, 2013 at 9:00 a.m. ET – SEATTLE, November 12, 2013 – Dendreon Corporation (Nasdaq: DNDN) today reported results for the third quarter ended September 30, 2013. Net product re |
|
| October 3, 2013 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 1, 2013 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| September 19, 2013 |
Financial Statements and Exhibits, Other Events - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 17, 2013 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (C |
|
| September 19, 2013 |
Dendreon Announces Marketing Authorization for PROVENGE® in the European Union EX-99.1 Exhibit 99.1 September 17, 2013 Dendreon Announces Marketing Authorization for PROVENGE® in the European Union SEATTLE—(BUSINESS WIRE)— September 17, 2013 — Dendreon Corporation (Nasdaq: DNDN) today announced that the European Commission (EC) has granted marketing authorization for PROVENGE® (autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or sipuleucel-T) dispersio |
|
| August 8, 2013 |
EX-99.1 Exhibit 99.1 Dendreon Announces Second Quarter 2013 Results – Conference Call to be Hosted August 8, 2013 at 4:30 p.m. ET – SEATTLE, August 8, 2013 – Dendreon Corporation (Nasdaq: DNDN) today reported results for the second quarter ended June 30, 2013. Net product revenue for the quarter was $73.3 million compared to $80.0 million for the quarter ended June 30, 2012, down 8.4% year over ye |
|
| August 8, 2013 |
Exhibit 10.1 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. THIRD AMENDMENT TO LEASE This THIRD AMENDMENT TO LEASE (this ?Amendment?) is dated for reference purposes as of the 16th day of April, 2013, between FSP-RIC, LLC (?Landlord?), and DENDREON CORPORATION, a Delaware corporation (?Tenant?). RECITALS A. Landlo |
|
| August 8, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2013 Dendreon Corporation (Exact Name of Registrant as Specified in Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| August 8, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2013 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-35546 DENDREON CORPORATION (Exact name of registrant as specified in its charter) DELAWARE 22-3203193 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No. |
|
| August 8, 2013 |
FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 5, 2013 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commi |
|
| August 8, 2013 |
S-8 POS 1 d581095ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on August 8, 2013 Registration No. 333-39634 Registration No. 333-143251 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-39634 FORM S-8 REGISTRATION STATEMENT NO. 333-143251 UNDER THE SECURITIES ACT OF 1933 DENDRE |
|
| August 8, 2013 |
S-8 POS As filed with the Securities and Exchange Commission on August 8, 2013 Registration No. |
|
| June 13, 2013 |
CORRESP June 13, 2013 VIA EDGAR Mr. Jim B. Rosenberg Senior Assistant Chief Accountant Division of Corporation Finance United States Securities and Exchange Commission 100 F Street NE Washington, DC 20549-4720 Re: Dendreon Corporation Form 10-K for the Fiscal Year Ended December 31, 2012 Filed February 25, 2013 Form 10-Q for the Quarterly Period Ended March 31, 2013 Filed May 9, 2013 File No. 001- |
|
| May 9, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2013 Dendreon Corporation (Exact Name of Registrant as Specified in Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| May 9, 2013 |
EX-99.1 Exhibit 99.1 Dendreon Announces First Quarter 2013 Results – Conference Call to be Hosted May 9, 2013 at 9:00 a.m. ET – SEATTLE, May 9, 2013 – Dendreon Corporation (Nasdaq: DNDN) today reported results for the first quarter ended March 31, 2013. Net product revenue for the quarter was $67.6 million compared to $82.0 million for the quarter ended March 31, 2012, down 17.6% year over year. N |
|
| May 9, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2013 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-35546 DENDREON CORPORATION (Exact name of registrant as specified in its charter) DELAWARE 22-3203193 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No. |
|
| April 26, 2013 |
Submission of Matters to a Vote of Security Holders - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 22, 2013 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commi |
|
| April 5, 2013 |
Definitive Proxy Statement Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 28, 2013 |
PRE 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 18, 2013 |
Dendreon Announces Securities Class Action Settlement EX-99.1 Exhibit 99.1 Dendreon Announces Securities Class Action Settlement SEATTLE— March 18, 2013—Dendreon Corporation (Nasdaq:DNDN) today announced that it has reached an agreement in principle to settle the securities class action litigation pending against it in the United States District Court for the Western District of Washington. Upon final approval, the settlement will resolve the claims |
|
| March 18, 2013 |
Financial Statements and Exhibits - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 18, 2013 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commi |
|
| March 6, 2013 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 6, 2013 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commis |
|
| March 4, 2013 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 4, 2013 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commis |
|
| February 25, 2013 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 Commission File Number 001-35546 DENDREON CORPORATION (Exact name of registrant as specified in its charter) DELAWARE 22-3203193 (State or other jurisdiction of incorporation or organization) (I. |
|
| February 25, 2013 |
AMENDMENT NO. 2 TO RIGHTS AGREEMENT EX-4.10 Exhibit 4.10 AMENDMENT NO. 2 TO RIGHTS AGREEMENT This AMENDMENT NO. 2 to RIGHTS AGREEMENT, dated as of February 14, 2013 (this “Amendment No. 2”), amends the Rights Agreement, dated as of September 18, 2002 and amended as of May 4, 2012 (the “Rights Agreement”), between Dendreon Corporation, a Delaware corporation (the “Company”), and Computershare Shareowner Services LLC (f/k/a/ Mellon In |
|
| February 25, 2013 |
EX-99.1 Exhibit 99.1 Dendreon Announces Fourth Quarter and 2012 Year End Results – Conference Call to be Hosted February 25, 2013 at 9:00 a.m. ET – SEATTLE, February 25, 2013 – Dendreon Corporation (Nasdaq: DNDN) today reported results for the fourth quarter and full year ended December 31, 2012. Net product revenue for the year ended December 31, 2012 was $325.3 million compared to $213.5 million |
|
| February 25, 2013 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 22, 2013 Dendreon Corporation (Exact Name of Registrant as Specified in Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commis |
|
| February 25, 2013 |
EX-21.1 Exhibit 21.1 Dendreon Corporation List of Subsidiaries Legal Name Jurisdiction Percent Owned Dendreon Holdings, LLC Delaware 100%1 Dendreon Distribution, LLC Delaware 100%2 Dendreon Manufacturing, LLC Delaware 100%3 Dendreon UK Limited England and Wales 100%4 Dendreon Holdings (Netherlands) B.V. The Netherlands 100%5 Dendreon Germany GmbH Germany 100%6 Dendreon Operations B.V. The Netherla |
|
| February 25, 2013 |
EX-12 Exhibit 12 Dendreon Corporation Ratios of Earnings to Fixed Charges Year Ended December 31, Ratio of Earnings to Fixed Charges (in thousands) 2012 2011 2010 2009 2008 Earnings Loss before taxes ($ 393,610 ) ($ 337,806 ) ($ 439,891 ) ($ 220,161 ) ($ 71,644 ) Add: Fixed charges 58,349 52,426 7,078 5,174 7,210 Less: Capitalized interest 290 1,186 3,539 1,374 586 Total earnings (as defined) (335 |
|
| February 12, 2013 |
DNDN / / VANGUARD GROUP INC Passive Investment dendreoncorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 0 )* Name of issuer: Dendreon Corp Title of Class of Securities: Common Stock CUSIP Number: 24823Q107 Date of Event Which Requires Filing of this Statement: December 31, 2012 Check the appropriate box to design |
|
| January 8, 2013 |
DNDN / / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. |
|
| January 7, 2013 |
DNDN / / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. |
|
| January 7, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 7, 2013 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Comm |
|
| January 7, 2013 |
Dendreon Announces Preliminary Fourth Quarter 2012 Revenues Press Release Exhibit 99.1 Dendreon Announces Preliminary Fourth Quarter 2012 Revenues SEATTLE, January 7, 2013 – Dendreon Corporation (NASDAQ: DNDN) today announced preliminary revenues for the fourth quarter ended December 31, 2012. Net product revenue for the quarter is expected to be approximately $85.5 million, which includes an approximate $3.8 million favorable adjustment to the Company’s c |
|
| December 21, 2012 |
Form S-8 As filed with the Securities and Exchange Commission on December 21, 2012 Registration No. |
|
| December 21, 2012 |
DENDREON CORPORATION 2013 EMPLOYEE STOCK PURCHASE PLAN Dendreon Corporation Employee Stock Purchase Plan Exhibit 99.1 DENDREON CORPORATION 2013 EMPLOYEE STOCK PURCHASE PLAN The purpose of this Plan is to provide eligible employees of Dendreon Corporation (the “Company”) and certain of its subsidiaries with opportunities to purchase shares of the Company’s common stock, $0.001 par value (the “Common Stock”), commencing on January 1, 2013. Ten Million ( |
|
| November 15, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 9, 2012 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Com |
|
| November 2, 2012 |
Second Amendment to Office Lease Exhibit 10.2 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. SECOND AMENDMENT TO OFFICE LEASE THIS SECOND AMENDMENT TO OFFICE LEASE (this “Second Amendment”) is dated for reference purposes July 27, 2012, and is by and among FSP-RIC LLC, a Delaware limited liability company (“Landlo |
|
| November 2, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2012 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-35546 DENDREON CORPORATION (Exact name of registrant as specified in its charter) DELAWARE (State or other jurisdiction of incorporation or organization) 22-3203193 (IRS Employer Identification No. |
|
| November 2, 2012 |
AMENDMENT NO. 1 TO THE EXECUTIVE EMPLOYMENT AGREEMENT Exhibit 10.3 AMENDMENT NO. 1 TO THE EXECUTIVE EMPLOYMENT AGREEMENT This Amendment No. 1 (this ?Amendment?) to the Executive Employment Agreement dated January 31, 2012 (the ?Employment Agreement?) by and between Dendreon Corporation, a corporation organized under the laws of the State of Delaware, and having a place of business at 1301 2nd Avenue, Seattle, Washington 98101 (the ?Company?), and Joh |
|
| November 2, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2012 Dendreon Corporation (Exact Name of Registrant as Specified in Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| November 2, 2012 |
Exhibit 10.1 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. FIRST AMENDMENT TO OFFICE LEASE THIS FIRST AMENDMENT TO OFFICE LEASE (this ?First Amendment?) is dated for reference purposes March 8, 2011, and is by and among THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY, a Wisconsin corporation (?Landlord?), and DEND |
|
| November 2, 2012 |
Press Release Exhibit 99.1 Dendreon Announces Third Quarter 2012 Results – Restructuring on Track – – Conference Call to be Hosted November 2, 2012 at 9:00 a.m. ET – SEATTLE, November 2, 2012 – Dendreon Corporation (Nasdaq: DNDN) today reported results for the quarter ended September 30, 2012. Net product revenue for the quarter was $78 million, compared to $61 million for the quarter ended Septem |
|
| September 28, 2012 |
Correspondence September 28, 2012 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549-4720 Attn: Jim B. Rosenberg Senior Assistant Chief Accountant Re: Dendreon Corporation Form 10-K for the Year Ended December 31, 2011 Filed February 29, 2012 File No. 001-35546 Current Report on Form 8-K Filed December 9, 2011 Dear Mr. Rosenberg: |
|
| September 19, 2012 |
Costs Associated with Exit or Disposal Activities - FORM 8-K AMENDMENT Form 8-K Amendment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| July 31, 2012 |
DENDREON CORPORATION 2009 EQUITY INCENTIVE PLAN 2009 Equity Incentive Plan, as amended Exhibit 10.1 DENDREON CORPORATION 2009 EQUITY INCENTIVE PLAN 1. Purpose. The purpose of the 2009 Equity Incentive Plan is to attract and retain directors, officers, other employees and consultants of Dendreon Corporation, a Delaware corporation, and its Subsidiaries and to provide to such persons incentives and rewards for superior performance. 2. Definitions |
|
| July 31, 2012 |
FORM S-8 As filed with the Securities and Exchange Commission on July 31, 2012 Registration No. |
|
| July 31, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2012 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-35546 DENDREON CORPORATION (Exact name of registrant as specified in its charter) DELAWARE 22-3203193 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No. |
|
| July 31, 2012 |
- POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 As filed with the Securities and Exchange Commission on July 31, 2012 Registration No. 333-179780 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 DENDREON CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware 22- |
|
| July 31, 2012 |
Office Lease Agreement Table of Contents Exhibit 10.2 OFFICE LEASE AGREEMENT BY AND BETWEEN WELLS REIT – BRIDGEWATER NJ, LLC, as the Landlord AND DENDREON CORPORATION, as the Tenant Bridgewater Crossing 200 Crossing Boulevard Bridgewater, New Jersey Table of Contents TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 ARTICLE II PREMISES 8 ARTICLE III TERM 8 ARTICLE IV BASE RENT 9 ARTICLE V INCREASES I |
|
| July 30, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 30, 2012 Dendreon Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-35546 22-3203193 (State or Other Jurisdiction of Incorporation) (Commis |
|
| July 30, 2012 |
Dendreon Corporation press release dated July 30, 2012. Exhibit 99.1 Dendreon Announces Second Quarter 2012 Results — Company Announces Strategic Restructuring to Accelerate Path to Profitability and Future Growth – — Conference Call to be Hosted July 30, 2012 at 4:30 p.m. ET/1:30 p.m. PT — SEATTLE, July 30, 2012 – Dendreon Corporation (Nasdaq: DNDN) today reported results for the quarter ended Ju |
|
| July 30, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2012 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35546 22-3203193 (State or other jurisdiction of incorporation) (Commission File Number) (I.R. |
|
| July 30, 2012 |
Dendreon Corporation press release dated July 30, 2012. Exhibit 99.1 Dendreon Announces Strategic Restructuring to Accelerate Path to Profitability and Future Growth Projected Annual Cost Savings of Approximately $150 Million Company Expects to be Cash-Flow Positive at Approximately $100 Million in Quarterly Net Product Revenue SEATTLE, July 30, 2012 — Dendreon Corporation (Nasdaq: DNDN) today ann |
|
| July 11, 2012 |
DNDN / / PRIMECAP MANAGEMENT CO/CA/ - SC 13G/A Passive Investment OMB APPROVAL UNITED STATES OMB Number: 3235-0145 SECURITIES AND EXCHANGE COMMISSION Expires: February 28, 2009 Washington, D. |
|
| June 14, 2012 |
Submission of Matters to a Vote of Security Holders - FORM 8-K Form 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2012 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-35546 22-3203193 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| June 4, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2012 Dendreon Corporation (Exact Name of Registrant as Specified in Charter) Delaware 000-30681 22-3203193 (State or Other Juris- diction of Incorporation) (Commissio |
|
| May 7, 2012 |
Form 8-A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 22-3203193 (State of incorporation or organization) (I.R.S. Employer Identification No.) 1301 2nd Ave |
|
| May 7, 2012 |
Press Release Exhibit 99.1 Dendreon Reports Net PROVENGE Product Revenues of $82 Million, Achieved 6.5% Quarter-Over-Quarter Growth — Conference Call to be Hosted May 7, 2012 at 4:30 p.m. ET/1:30 p.m. PT – SEATTLE, May 7, 2012 — Dendreon Corporation (Nasdaq: DNDN) today reported results for the quarter ended March 31, 2012. Net product revenue for the quarter was $82.0 million compared to $27.0 mi |
|
| May 7, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K Form 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2012 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35546 22-3203193 (State or other jurisdiction (Commission File Number) (I.R.S. Employer |
|
| May 7, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2012 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-30681 DENDREON CORPORATION (Exact name of registrant as specified in its charter) DELAWARE 22-3203193 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No. |
|
| May 7, 2012 |
Certificate of Amendment of Certificate of Designation Exhibit 3.1 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF DESIGNATION OF SERIES A JUNIOR PARTICIPATING PREFERRED STOCK OF DENDREON CORPORATION (Pursuant to Section 151 of the General Corporation Law of the State of Delaware) Dendreon Corporation (hereinafter called the “Corporation”), a corporation organized and existing under and by virtue of th |
|
| May 7, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2012 Dendreon Corporation (Exact Name of Registrant as Specified in Charter) Delaware 000-30681 22-3203193 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| May 7, 2012 |
AMENDMENT NO. 1 TO RIGHTS AGREEMENT Amendment No. 1 Exhibit 4.1 AMENDMENT NO. 1 TO RIGHTS AGREEMENT This AMENDMENT NO. 1 to RIGHTS AGREEMENT, dated as of May 4, 2012 (this “Amendment”), amends that certain Rights Agreement, dated as of September 18, 2002, between Dendreon Corporation, a Delaware corporation (the “Company”), and Computershare Shareowner Services LLC (f/k/a Mellon Investor Services LLC), a New Jersey limited liability |
|
| April 27, 2012 |
Definitive Proxy Statement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 27, 2012 |
- DEFINITIVE ADDITIONAL MATERIALS Definitive Additional Materials UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 20, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2012 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction (Commission File Number) (I.R.S. Employer of in |
|
| March 1, 2012 |
Exhibit 99.1 Dendreon Announces Executive Appointments — Joe DePinto Named Executive Vice President, Global Commercial Operations — — Robert S. Poulton Named Executive Vice President, Technical Operations — — Christine Mikail Named Executive Vice President, Corporate Development, General Counsel, Secretary — SEATTLE-(BUSINESS WIRE)- February 28, 2012-Dendreon Corporation (Nasdaq:DNDN) today announ |
|
| March 1, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2012 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction (Commission File Number) (I.R.S. Employer of |
|
| February 29, 2012 |
Exhibit 21.1 Dendreon Corporation List of Subsidiaries Legal Name Jurisdiction Percent Owned Dendreon Holdings, LLC Delaware 100%1 Dendreon Distribution, LLC Delaware 100%2 Dendreon Manufacturing, LLC Delaware 100%3 Dendreon UK Limited England and Wales 100%4 Dendreon Holdings (Netherlands) B.V. The Netherlands 100%5 Dendreon Germany GmbH Germany 100%6 Dendreon Operations B.V. The Netherlands 100% |
|
| February 29, 2012 |
Form S-8 As filed with the Securities and Exchange Commission on February 29, 2012 Registration No. |
|
| February 29, 2012 |
DENDREON CORPORATION INCENTIVE PLAN SECTION 1. BACKGROUND, PURPOSE AND DURATION Exhibit 10.30 DENDREON CORPORATION INCENTIVE PLAN SECTION 1. BACKGROUND, PURPOSE AND DURATION 1.1. Effective Date. The Plan was originally effective on January 1, 2005. This amendment and restatement of the Plan is effective as of January 1, 2012. 1.2. Purpose of the Plan. The Plan is designed to motivate certain employees to achieve specified annual corporate objectives. SECTION 2. DEFINITIONS Th |
|
| February 29, 2012 |
Form 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 Commission File Number 000-30681 DENDREON CORPORATION (Exact name of registrant as specified in its charter) DELAWARE 22-3203193 (State or other jurisdiction of incorporation or organization) (I. |
|
| February 29, 2012 |
Exhibit 12 Dendreon Corporation Ratios of Earnings to Fixed Charges Year Ended December 31, Ratio of Earnings to Fixed Charges (in thousands) 2011 2010 2009 2008 2007 Earnings Loss before taxes ($ 337,806 ) ($ 439,891 ) ($ 220,161 ) ($ 71,644 ) ($ 99,264 ) Add: Fixed charges 52,426 7,078 5,174 7,210 5,888 Less: Capitalized interest 1,186 3,539 1,374 586 229 Total earnings (as defined) (286,566 ) ( |
|
| February 29, 2012 |
DENDREON CORPORATION (RESTRICTED) STOCK AWARD AGREEMENT Exhibit 10.29 DENDREON CORPORATION (RESTRICTED) STOCK AWARD AGREEMENT Pursuant to the (Restricted) Stock Award Grant Notice (?Grant Notice?) and this Stock Award Agreement (?Agreement?) is entered into as of date on grant notice, between Dendreon Corporation, a Delaware corporation (the ?Company?), and you (the ?Participant?). WHEREAS, the Company desires to award restricted stock to Participant u |
|
| February 27, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - FOEM 8-K Foem 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2012 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction of incorporation) (Commission File |
|
| February 27, 2012 |
Press Release Exhibit 99.1 Dendreon Reports Fourth Quarter and 2011 Year End Financial Results — Conference Call to be Hosted February 27, 2012 at 9:00 a.m. ET/6:00 a.m. PT — SEATTLE, February 27, 2012 — Dendreon Corporation (Nasdaq: DNDN) today reported results for the year and quarter ended December 31, 2011. Product revenue for the year ended December 31, 2011 was $213.5 million compared to $48 |
|
| February 14, 2012 |
DNDN / / SAC Capital Advisors LP - SCHEDULE 13G/A, AMENDMENT #3 Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* DENDREON CORPORATION (Name of Issuer) Common Stock, Par Value $0.001 Per Share (Title of Class of Securities) 24823Q107 (CUSIP Number) December 31, 2011 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| February 13, 2012 |
DNDN / / PRIMECAP MANAGEMENT CO/CA/ - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response: 10.4 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Dendreon Corp. (Name of Issuer) Common (Title of Class of Securities) 24823Q107 (CUSIP Number) December 31, 2011 (Date of Event Which Requires |
|
| February 3, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 31, 2012 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction (Commission File Number) (I.R.S. Employer of |
|
| February 3, 2012 |
AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT Exhibit 10.1 AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT This Amendment to Executive Employment Agreement (“Amendment”) is entered into as of the date of the last signature to this Amendment (“Effective Date”), by and between Dendreon Corporation, a Delaware corporation (the “Company”), and Mitchell H. Gold, M.D. (“Employee”). This Amendment amends the Executive Employment Agreement (“Agreement”) |
|
| February 3, 2012 |
Exhibit 10.2 EMPLOYMENT AGREEMENT This Agreement is made, entered into, and is effective as of the Effective Date, by and between the Company and the Executive. Article 1. Employment 1.1 The Company hereby agrees to employ the Executive and the Executive hereby agrees to serve the Company in accordance with the terms and conditions set forth herein for a period of three years, commencing as of the |
|
| January 19, 2012 |
DENDREON CORPORATION 2012 EQUITY INCENTIVE INDUCEMENT AWARD PLAN 2012 Equity Incentive Inducement Award Plan Exhibit 10.1 DENDREON CORPORATION 2012 EQUITY INCENTIVE INDUCEMENT AWARD PLAN 1. Purpose. The purpose of the 2012 Equity Incentive Inducement Award Plan is to attract and retain employees of Dendreon Corporation, a Delaware corporation, and its Subsidiaries and to provide to such persons incentives and rewards for superior performance. 2. Definitions. As |
|
| January 19, 2012 |
DENDREON CORPORATION RESTRICTED STOCK AGREEMENT Form of Restricted Stock Agreement Exhibit 10.3 DENDREON CORPORATION RESTRICTED STOCK AGREEMENT Pursuant to the Restricted Stock Award Grant Notice (“Grant Notice”), this Restricted Stock Agreement (“Agreement”) is entered into as of the date of the Grant Notice, between Dendreon Corporation, a Delaware corporation (the “Company”), and you (the “Participant”) as a material inducement to your decis |
|
| January 19, 2012 |
Form of Nonstatutory Stock Option Agreement Exhibit 10.2 DENDREON CORPORATION 2012 EQUITY INCENTIVE INDUCEMENT AWARD PLAN STOCK OPTION AGREEMENT (NONSTATUTORY STOCK OPTIONS) Pursuant to your Stock Option Grant Notice (“Grant Notice”), this Stock Option Agreement (the “Agreement”), is entered into as of the date of the Grant Notice, between Dendreon Corporation, a Delaware corporation (the “Company |
|
| January 19, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 12, 2012 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction of incorporation) (Comm |
|
| December 9, 2011 |
Financial Statements and Exhibits, Other Events SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2011 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction (Commission File Number) (I.R.S. Employer of |
|
| December 9, 2011 |
Dendreon Agrees to Sell VICTRELIS™ (boceprevir) Royalty Interest for $125 Million Exhibit 99.1 Dendreon Agrees to Sell VICTRELIS™ (boceprevir) Royalty Interest for $125 Million SEATTLE-Dendreon Corporation (NASDAQ:DNDN) today announced that it has agreed to sell for $125 million in cash its royalty interest related to intellectual property licensed to Schering-Plough Ltd. and Schering Corporation (collectively Schering, each now a wholly owned subsidiary of Merck & Co., Inc.) a |
|
| December 7, 2011 |
Amended and Restated Bylaws of Dendreon Corporation. Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF DENDREON CORPORATION (A DELAWARE CORPORATION) December 1, 2011 Table of Contents Page ARTICLE I Offices 1 Section 1. Registered Office 1 Section 2. Other Offices 1 ARTICLE II Corporate Seal 1 Section 3. Corporate Seal 1 ARTICLE III Stockholders’ Meetings 1 Section 4. Place Of Meetings 1 Section 5. Annua |
|
| December 7, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2011 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction of incorporation) (Commission File Number) (I |
|
| November 18, 2011 |
POWER OF ATTORNEY Know by all these presents, that the undersigned hereby authorizes Mitchell H. |
|
| November 8, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2011 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction (Commission File Number) (I.R.S. Employer of |
|
| November 8, 2011 |
Dendreon Announces Election of Dennis M. Fenton to Board of Directors Exhibit 99.1 Dendreon Announces Election of Dennis M. Fenton to Board of Directors SEATTLE-(BUSINESS WIRE)- Dendreon Corporation (Nasdaq: DNDN) today announced that Dennis M. Fenton has been elected to the Company's Board of Directors, effective November 8, 2011. Dr. Fenton has 30 years of pharmaceutical and biotechnology experience, including over two decades at Amgen, Inc., where he played an in |
|
| November 2, 2011 |
DENDREON CORPORATION EXECUTIVE EMPLOYMENT AGREEMENT (WASHINGTON STATE) Exhibit 10.1 DENDREON CORPORATION EXECUTIVE EMPLOYMENT AGREEMENT (WASHINGTON STATE) This Executive Employment Agreement (this ?Agreement?) is entered into as of the date of the last signature to this Agreement (?Effective Date?), by and between Dendreon Corporation, a Delaware corporation (the ?Company?), and [NAME] (?Employee?). The parties agree as follows: 1. Employment. The Company hereby empl |
|
| November 2, 2011 |
Exhibit 99.1 Dendreon Reports Third Quarter 2011 Financial Results ? Gross Product Revenue of Approximately $66MM in Q3 ? SEATTLE, November 2, 2011 ? Dendreon Corporation (Nasdaq: DNDN) today reported results for the third quarter ended September 30, 2011. Net revenue for the quarter ended September 30, 2011 was $64.3 million compared to $20.2 million for the quarter ended September 30, 2010. This |
|
| November 2, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q 10-Q 1 d237118d10q.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2011 SEPTEMBER 30, 2011 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITI |
|
| November 2, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2011 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction of incorporation) (Commission File Number) (I |
|
| September 13, 2011 |
POWER OF ATTORNEY Know by all these presents, that the undersigned hereby authorizes Mitchell H. |
|
| September 8, 2011 |
Dendreon Announces Company Restructuring and Provides Update on PROVENGE Exhibit 99.1 Dendreon Announces Company Restructuring and Provides Update on PROVENGE SEATTLE, September 8, 2011 – Dendreon Corporation (Nasdaq: DNDN) today announced restructuring plans, overall cost reductions, and an update on PROVENGE® (sipuleucel-T) sales. Dendreon reported August gross revenues of approximately $22 million. Dendreon continues to expect modest quarter-over-quarter growth as i |
|
| September 8, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2011 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction (Commission File Number) (I.R.S. Employer of |
|
| September 8, 2011 |
SEPARATION AND RELEASE AND TRANSITIONAL SERVICES AGREEMENT Exhibit 10.1 SEPARATION AND RELEASE AND TRANSITIONAL SERVICES AGREEMENT I, Hans Bishop, understand and agree that all aspects of my employment at Dendreon Corporation (the "Company") will cease effective September 30, 2011 (“Termination Date”). The Company agrees that as of the Termination Date, the termination is pursuant to Section 6.2(a) of my Executive Employment Agreement effective as of May |
|
| September 8, 2011 |
POWER OF ATTORNEY Know by all these presents, that the undersigned hereby authorizes Greg Schiffman or Gregory Cox of Dendreon Corporation, a Delaware corporation (the “Company”), to execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer, director or 10% stockholder of the Company, Forms 3, 4, and 5, and any Amendments thereto, and cause such form(s) to be filed with the United States Securities and Exchange Commission pursuant to Section 16(a) of the Securities Act of 1934, relating to the undersigned’s beneficial ownership of securities in the Company. |
|
| September 6, 2011 |
Termination of a Material Definitive Agreement SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 1, 2011 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction (Commission File Number) (I.R.S. Employer of |
|
| August 31, 2011 |
Dendreon Appoints John E. Osborn EVP & General Counsel Exhibit 99.1 Dendreon Appoints John E. Osborn EVP & General Counsel SEATTLE-(BUSINESS WIRE)- Dendreon Corporation (Nasdaq: DNDN) today announced the appointment of John E. Osborn as executive vice president, general counsel and corporate secretary, effective August 30. Mr. Osborn has more than 25 years' experience in law, business, and public policy. He previously served as general counsel with tw |
|
| August 31, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 30, 2011 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction (Commission File Number) (I.R.S. Employer of i |
|
| August 31, 2011 |
Exhibit 10.1 Execution Copy DENDREON CORPORATION EXECUTIVE EMPLOYMENT AGREEMENT (WASHINGTON STATE) This Executive Employment Agreement (this “Agreement”) is entered into as of the date of the last signature to this Agreement (“Effective Date”), by and between Dendreon Corporation, a Delaware corporation (the “Company”), and John E. Osborn (“Employee”). The parties agree as follows: 1. Employment. |
|
| August 30, 2011 |
POWER OF ATTORNEY Know by all these presents, that the undersigned hereby authorizes Mitchell H. |
|
| August 29, 2011 |
FDA Approves Dendreon's Atlanta Cancer Immunotherapy Manufacturing Facility Exhibit 99.1 FDA Approves Dendreon's Atlanta Cancer Immunotherapy Manufacturing Facility SEATTLE-(BUSINESS WIRE)- Dendreon Corporation (Nasdaq:DNDN) today announced that the U.S. Food and Drug Administration (FDA) approved its Atlanta cancer immunotherapy manufacturing facility, the third location at which the Company will produce PROVENGE? (sipuleucel-T) to help meet the needs of patients across |
|
| August 29, 2011 |
Financial Statements and Exhibits, Other Events SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 26, 2011 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction (Commission File Number) (I.R.S. Employer of i |
|
| August 22, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 18, 2011 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction (Commission File Number) (I.R.S. Employer of i |
|
| August 22, 2011 |
Dendreon Announces Election of John H. Johnson to Board of Directors Exhibit 99.1 Dendreon Announces Election of John H. Johnson to Board of Directors SEATTLE-(BUSINESS WIRE)- Dendreon Corporation (Nasdaq: DNDN) today announced that John H. Johnson has been elected to the Company's Board of Directors, effective August 18, 2011. Mr. Johnson is currently the chief executive officer of Savient Pharmaceuticals, Inc. (Nasdaq: SVNT), where he has also served as a member |
|
| August 3, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2011 JUNE 30, 2011 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-30681 DENDREON CORPORATION (Exact name of registrant as specified in its charter) DELAWARE (State or other jurisdiction of incorporation or organization) 22-3203193 (IRS Employer Identification No. |
|
| August 3, 2011 |
Exhibit 99.1 Dendreon Reports Second Quarter 2011 Financial Results - Gross Revenue of Approximately $51MM in Q2 ? - Shift in Launch Trajectory Based on More Gradual Adoption - - Recent Positive Reimbursement Changes Expected to Have Significant Impact - - Company Expects Modest Quarter over Quarter Revenue Growth for Remainder of 2011- SEATTLE, August 3, 2011 ? Dendreon Corporation (Nasdaq: DNDN) |
|
| August 3, 2011 |
Financial Statements and Exhibits, Results of Operations and Financial Condition SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2011 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction (Commission File Number) (I.R.S. Employer of in |
|
| August 2, 2011 |
Correspondence Letter August 2, 2011 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549-4720 Attn: Jim B. Rosenberg and Sasha S. Parikh Re: Dendreon Corporation Form 10-K for the Year Ended December 31, 2010 Filed March 1, 2011 Form 10-Q for the Quarter Ended March 31, 2011 Filed May 2, 2011 (File No. 0-30681) Ladies and Gentlemen: Reference is made to the lett |
|
| August 2, 2011 |
POWER OF ATTORNEY Know by all these presents, that the undersigned hereby authorizes Mitchell H. |
|
| August 2, 2011 |
POWER OF ATTORNEY Know by all these presents, that the undersigned hereby authorizes Mitchell H. |
|
| July 25, 2011 |
POWER OF ATTORNEY Know by all these presents, that the undersigned hereby authorizes Mitchell H. |
|
| July 25, 2011 |
POWER OF ATTORNEY Know by all these presents, that the undersigned hereby authorizes Mitchell H. |
|
| July 25, 2011 |
POWER OF ATTORNEY Know by all these presents, that the undersigned hereby authorizes Richard J. |
|
| July 25, 2011 |
POWER OF ATTORNEY Know by all these presents, that the undersigned hereby authorizes Mitchell H. |
|
| July 25, 2011 |
POWER OF ATTORNEY Know by all these presents, that the undersigned hereby authorizes Richard J. |
|
| July 19, 2011 |
POWER OF ATTORNEY Know by all these presents, that the undersigned hereby authorizes Mitchell H. |
|
| July 19, 2011 |
POWER OF ATTORNEY Know by all these presents, that the undersigned hereby authorizes Mitchell H. |
|
| July 19, 2011 |
POWER OF ATTORNEY Know by all these presents, that the undersigned hereby authorizes Mitchell H. |
|
| July 19, 2011 |
POWER OF ATTORNEY Know by all these presents, that the undersigned hereby authorizes Richard J. |
|
| July 1, 2011 |
Exhibit 99.1 FDA Approves Dendreon?s Los Angeles Cancer Immunotherapy Manufacturing Facility ?FDA Approval of 36 Workstations Further Supports National Availability of First-in-Class Prostate Cancer Immunotherapy PROVENGE? SEATTLE, June 29, 2011 ? Dendreon Corporation (Nasdaq: DNDN) today announced that the U.S. Food and Drug Administration (FDA) approved its Los Angeles cancer immunotherapy manuf |
|
| July 1, 2011 |
Financial Statements and Exhibits, Other Events SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 29, 2011 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction (Commission File Number) (I.R.S. Employer of inc |
|
| July 1, 2011 |
Exhibit 99.2 Dendreon Announces Increased Capacity and Significant Reimbursement Decisions Supporting Broad Availability of PROVENGE - FDA Approves Los Angeles Immunotherapy Manufacturing Facility, CMS Announces National Coverage Decision, and Product Specific Q-Code Effective - SEATTLE, June 30, 2011 /PRNewswire/ - Dendreon Corporation (Nasdaq: DNDN) today announced significant milestones that su |
|
| June 23, 2011 |
June 23, 2011 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549-4720 Attn: Jim B. Rosenberg and Sasha S. Parikh Re: Dendreon Corporation Form 10-K for the Year Ended December 31, 2010 Filed March 1, 2011 Form 10-Q for the Quarter Ended March 31, 2011 Filed May 2, 2011 (File No. 0-30681) Ladies and Gentlemen: Reference is made to the letter dated May 27, 2011 s |
|
| June 23, 2011 |
Submission of Matters to a Vote of Security Holders SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2011 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction (Commission File Number) (I.R.S. Employer of inc |
|
| June 3, 2011 |
June 3, 2011 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549-4720 Attn: Jim B. Rosenberg and Sasha S. Parikh Re: Dendreon Corporation Form 10-K for the Year Ended December 31, 2010 Filed March 1, 2011 Form 10-Q for the Quarter Ended March 31, 2011 Filed May 2, 2011 (File No. 0-30681) Ladies and Gentlemen: Reference is made to the letter dated May 27, 2011 se |
|
| June 2, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2011 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction (Commission File Number) (I.R.S. Employer of inco |
|
| May 2, 2011 |
EX-99.1 2 v59035exv99w1.htm EX-99.1 Exhibit 99.1 Dendreon Reports First Quarter 2011 Financial Results Conference Call to be Hosted May 2, 2011 at 4:30 p.m. ET SEATTLE, May 2, 2011 — Dendreon Corporation (Nasdaq: DNDN) today reported results for the first quarter ended March 31, 2011. Revenue for the quarter ended March 31, 2011 was $28.1 million compared to $21,000 for the quarter ended March 31, |
|
| May 2, 2011 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2011 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-30681 (Commission File Number) 22-3 |
|
| May 2, 2011 |
e10vq Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2011 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-30681 DENDREON CORPORATION (Exact name of registrant as specified in its charter) DELAWARE 22-3203193 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No. |
|
| April 29, 2011 |
def14a Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ |
|
| April 7, 2011 |
OMB APPROVAL UNITED STATES OMB Number: 3235-0145 SECURITIES AND EXCHANGE COMMISSION Expires: February 28, 2009 Washington, D. |
|
| March 31, 2011 |
Dendreon Statement on CMS Proposed Decision Memo for PROVENGE® Exhibit 99.1 Dendreon Statement on CMS Proposed Decision Memo for PROVENGE® SEATTLE, March 30, 2011 – Dendreon Corporation (Nasdaq: DNDN) announced today that the Centers for Medicare and Medicaid Services (CMS) has issued a proposed decision memo for PROVENGE® (sipuleucel-T). Dendreon appreciates the work and diligent scientific review conducted by CMS that resulted in the draft decision memo, in |
|
| March 31, 2011 |
Financial Statements and Exhibits, Other Events SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2011 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction (Commission File Number) (I.R.S. Employer of in |
|
| March 11, 2011 |
Exhibit 99.1 Dendreon Expands Launch of PROVENGE -FDA Approval of Additional 36 Workstations in New Jersey Manufacturing Facility Provides Increased Availability of First-in-Class Prostate Cancer Immunotherapy PROVENGE- SEATTLE, March 10, 2011 /PRNewswire/ - Dendreon Corporation (Nasdaq: DNDN) announced today that the U.S. Food and Drug Administration (FDA) approved the remainder of its New Jersey |
|
| March 11, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 9, 2011 DENDREON CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-30681 22-3203193 (State or other jurisdiction (Commission File Number) (I.R.S. Employer of inc |
